Papers |
Prognostic significance of hypoxia-inducible factor-1 alpha, TWIST1 and Snail expression in resectable non-small cell lung cancer
1 Taipei Veterans General Hospital, Taiwan
2 National Yang-Ming University, Taiwan
* To whom correspondence should be addressed. E-mail: bradley.hung{at}gmail.com.
Accepted 8 September 2009
Abstract
Objective: Metastasis is the most common cause of disease failure and mortality for non-small cell lung cancer (NSCLC) after surgical resection. Both Snail and TWIST1 are epithelial-mesenchymal transition (EMT) regulators which induce metastasis. Intratumoral hypoxia followed by stabilization of hypoxia-inducible factor-1
(HIF-1
) promotes metastasis through regulation of certain EMT regulators. The aim of this study is to evaluate the prognostic value of HIF-1
, TWIST1 and Snail expression in resectable NSCLC patients.
Methods: A retrospective analysis of 87 patients with resectable NSCLC from Taipei Veterans General Hospital between 2003 and 2004 was performed using immunohistochemistry to analyze HIF-1
, TWIST1 and Snail expression. The association between HIF-1
, TWIST1 and Snail expression and patients' overall and recurrence-free survivals was investigated.
Results: Overexpression of HIF-1
, TWIST1 or Snail was shown in 32.2%, 36.8% and 55.2% of primary tumors, respectively. Overexpression of HIF-1
, TWIST1 or Snail in primary NSCLCs was associated with a shorter overall survival (P = 0.005, 0.026, 0.009, respectively), and overexpression of HIF-1
was associated with a shorter recurrence-free survival (P = 0.016). We categorized the patients into four groups according to the positivity of HIF-1
/TWIST1/Snail to investigate the accumulated effects of these markers on survival. Co-expression of more than two markers was an independent prognostic indicator for both recurrence-free survival and overall survival (P = 0.004 and < 0.001, respectively, by multivariate Cox proportional hazards model).
Conclusions: Co-expression of more than two markers from HIF-1
, TWIST1 and Snail is a significant prognostic predictor in NSCLC patients.
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
